SCHEMBL26435409

SCHEMBL26435409

c1ccc(-c2nc(-c3ccc4sc5ccccc5c4c3)nc(-c3cccc4ccc5ccccc5c34)n2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HSD17B10 Q99714 4/20 0.41
ALDH1A1 P00352 3/20 0.41
TP53 P04637 3/20 0.41
NPC1 O15118 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 1/20 0.39
TGFBR1 P36897 1/20 0.39
MIF P14174 1/20 0.38
GABRA1 P14867 1/20 0.38
AHR P35869 1/20 0.37
MAPK14 Q16539 5/20 0.36
DCTPP1 Q9H773 1/20 0.36
TSHR P16473 3/20 0.36
LMNA P02545 2/20 0.36
PKM P14618 1/20 0.36
KLF5 Q13887 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435375 0.89 ALOX5 (0.36) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435376 0.86 PIM3 (0.37) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435411 0.86 CCR1 (0.34) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435410 0.86 NPC1 (0.37) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435296 0.85 ALOX5 (0.44) MAPTPIK3CDPIK3CAPIK3CGLIMK1
SCHEMBL26435378 0.85 PIM3 (0.39) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435379 0.85 F9 (0.36) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435385 0.85 ALDH1A1 (0.35) HSD17B10ALDH1A1MAPTHPGDMAPK1
SCHEMBL26435357 0.84 ALDH1A1 (0.34) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53
SCHEMBL26435412 0.84 F9 (0.36) KDM4ESMN1; SMN2HSD17B10ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 KDM4E 1841/4885SMN1; SMN2 2642/4885HSD17B10 4425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.